Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+7.66%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$14.4B
AUM Growth
+$1.36B
Cap. Flow
+$220M
Cap. Flow %
1.53%
Top 10 Hldgs %
37.22%
Holding
1,339
New
25
Increased
736
Reduced
239
Closed
23

Sector Composition

1 Real Estate 55.07%
2 Technology 11.49%
3 Consumer Discretionary 4.63%
4 Healthcare 4.39%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AKRO icon
1101
Akero Therapeutics
AKRO
$3.58B
$7K ﹤0.01%
188
AMPH icon
1102
Amphastar Pharmaceuticals
AMPH
$1.37B
$7K ﹤0.01%
194
FGEN icon
1103
FibroGen
FGEN
$48.9M
$7K ﹤0.01%
15
KYMR icon
1104
Kymera Therapeutics
KYMR
$3.11B
$7K ﹤0.01%
221
MRVI icon
1105
Maravai LifeSciences
MRVI
$363M
$7K ﹤0.01%
490
PCRX icon
1106
Pacira BioSciences
PCRX
$1.19B
$7K ﹤0.01%
169
AUPH icon
1107
Aurinia Pharmaceuticals
AUPH
$1.63B
$6K ﹤0.01%
528
BCRX icon
1108
BioCryst Pharmaceuticals
BCRX
$1.74B
$6K ﹤0.01%
692
GMAB icon
1109
Genmab
GMAB
$16.9B
$6K ﹤0.01%
172
IRWD icon
1110
Ironwood Pharmaceuticals
IRWD
$188M
$6K ﹤0.01%
573
SWTX
1111
DELISTED
SpringWorks Therapeutics
SWTX
$6K ﹤0.01%
251
TVTX icon
1112
Travere Therapeutics
TVTX
$1.93B
$6K ﹤0.01%
258
VCYT icon
1113
Veracyte
VCYT
$2.55B
$6K ﹤0.01%
266
XNCR icon
1114
Xencor
XNCR
$610M
$6K ﹤0.01%
222
MORF
1115
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$6K ﹤0.01%
155
DICE
1116
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$6K ﹤0.01%
192
ACLX icon
1117
Arcellx
ACLX
$4.03B
$5K ﹤0.01%
176
ADPT icon
1118
Adaptive Biotechnologies
ADPT
$1.96B
$5K ﹤0.01%
530
AGIO icon
1119
Agios Pharmaceuticals
AGIO
$2.09B
$5K ﹤0.01%
204
ARVN icon
1120
Arvinas
ARVN
$575M
$5K ﹤0.01%
198
DBC icon
1121
Invesco DB Commodity Index Tracking Fund
DBC
$1.26B
$5K ﹤0.01%
200
IMCR icon
1122
Immunocore
IMCR
$1.87B
$5K ﹤0.01%
104
IOVA icon
1123
Iovance Biotherapeutics
IOVA
$901M
$5K ﹤0.01%
877
+291
+50% +$1.66K
KROS icon
1124
Keros Therapeutics
KROS
$633M
$5K ﹤0.01%
111
RCKT icon
1125
Rocket Pharmaceuticals
RCKT
$354M
$5K ﹤0.01%
304